Hair analysis by immunological methods from the beginning to 2000.

Area of Science:

• Forensic Toxicology
• Analytical Chemistry
• Immunoassay Development

Background:

• Hair testing for drugs of abuse requires specialized immunoassays due to unique analytes (parent drugs and lipophilic metabolites) and matrix effects.
• Standard urine drug immunoassays are unsuitable for hair analysis because they lack specificity for hair-borne drug forms and are prone to interference.

Purpose of the Study:

• To outline the critical requirements for developing and validating immunoassays for hair drug testing.
• To emphasize the importance of appropriate antibody selection, matrix interference mitigation, and optimized cutoffs for accurate hair drug screening.

Main Methods:

• Review of immunoassay principles and their application to hair matrix analysis.
• Discussion of solid-phase immunoassays (e.g., coated-tube RIA, coated-plate ELISA) versus homogeneous assays for hair testing.
• Emphasis on optimizing assay cutoffs based on drug concentrations in known user and non-user hair samples.

Main Results:

• Immunoassays for hair testing must exhibit cross-reactivity with hair analytes and minimize matrix interference.
• Solid-phase immunoassays are preferred over homogeneous assays due to reduced hair matrix interference.
• Optimized cutoffs are crucial for achieving >90% sensitivity and specificity, avoiding false positives near the limit of detection.

Conclusions:

• Immunoassays are valuable for rapid, cost-effective screening of hair for drugs of abuse.
• Forensic confirmation requires a non-immunoassay method (e.g., chromatography) on a separate aliquot to ensure validity.
• Future immunoassay development will continue to enhance automated drug screening procedures.